Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase 3 4Phase 2 3Phase NA 2Phase 1 2

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Endocrine 4

Conditions

Neuroendocrine Tumors 32Multiple Endocrine Neoplasia Type 1 9Neoplasms 8Pituitary Neoplasms 7Carcinoid Tumor 7Pituitary ACTH Hypersecretion 6Gastro-enteropancreatic neuroendocrine tumor 6Differentiated Thyroid Cancer 6Adrenocortical Carcinoma 6Thyroid Cancer, Papillary 5Pituitary Diseases 5Pheochromocytoma 5Thyroid Neoplasms 4Serotonin Syndrome 4Neuroblastoma 4Cushing Syndrome 4Breast Neoplasms 4Acromegaly 4ACTH Syndrome, Ectopic 4Sarcoma 3Liposarcoma 3Insulinoma 3Fibrosarcoma 3Endometrial Neoplasms 3Carcinoma, Medullary 3Adenoma, Islet Cell 3Adenocarcinoma, Follicular 3Sarcoma, Synovial 2Sarcoma, Endometrial Stromal 2Parkinson Disease 2

Interventions

pasireotide 2lanreotide 1Solutions 1Radiosurgery 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Acromegaly × Endocrine × Clear all
NCT02419664 2022-03-31

Ga-68-DOTATOC -PET in the Management of Pituitary Tumours

Göteborg University

Phase 3 Terminated
22 enrolled
Endocrine

Acromegaly, Pituitary Diseases, Pituitary Neoplasms

NCT02354508 2019-12-10

Pasireotide in Patients With Acromegaly Inadequately Controlled With First Generation Somatostatin Analogues

Novartis

Phase 3 Completed
123 enrolled 27 charts
Endocrine

Acromegaly, Gigantism, Growth Disorders, Pituitary Neoplasms

NCT01137682 2018-04-05

PAOLA

Novartis

Phase 3 Completed
198 enrolled 17 charts
Endocrine

Acromegaly, Pituitary Neoplasms

NCT03439709 2018-03-01

MERGE

Samsung Medical Center

Phase 3 Unknown
90 enrolled
Endocrine

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡